[HTML][HTML] Metabolic modulation: Pneumocystis phosphoglucomutase is a target influencing host recognition
TJ Kottom, EM Carmona, B Lepenies… - The Cell Surface, 2024 - ncbi.nlm.nih.gov
Herein, this manuscript explores the significance of the phosphoglucomutase (PGM)
enzyme in Pneumocystis spp., focusing on its role in fungal surface mannoprotein formation …
enzyme in Pneumocystis spp., focusing on its role in fungal surface mannoprotein formation …
Pneumocystis jirovecii Pneumonia in HIV-Negative, Non-transplant Patients: Epidemiology, Clinical Manifestations, Diagnosis, Treatment, and Prevention
S Rhoads, J Maloney, A Mantha, R Van Hook… - Current Fungal Infection …, 2024 - Springer
Abstract Purpose of Review Pneumocystis jirovecii pneumonia (PJP) is an opportunistic
fungal infection that is increasingly seen in HIV-negative patients with immune compromise …
fungal infection that is increasingly seen in HIV-negative patients with immune compromise …
Pneumocystis pneumonia in French intensive care units in 2013–2019: mortality and immunocompromised conditions
T Kamel, T Boulain - Annals of Intensive Care, 2024 - Springer
Purpose The recent epidemiology of Pneumocystis pneumonia (PCP) requiring intensive
care unit (ICU) admission and the associated spectrum of immunocompromising conditions …
care unit (ICU) admission and the associated spectrum of immunocompromising conditions …
Pneumocystis pneumonia in intensive care: clinical spectrum, prophylaxis patterns, antibiotic treatment delay impact, and role of corticosteroids. A French multicentre …
T Kamel, R Janssen-Langenstein, Q Quelven… - Intensive Care …, 2024 - Springer
Abstract Purpose Severe Pneumocystis jirovecii pneumonia (PJP) requiring intensive care
has been the subject of few prospective studies. It is unclear whether delayed curative …
has been the subject of few prospective studies. It is unclear whether delayed curative …
[HTML][HTML] Pneumocystis jirovecii Pneumonia (PCP) in a Non-HIV Lung Cancer Patient in the Absence of Common Risk Factors
S Hashmi, D Yousuf, P Kumar - Cureus, 2023 - ncbi.nlm.nih.gov
Pneumocystis jirovecii pneumonia (PCP) has been described mainly in AIDs and in
immunocompromised patients with hematological malignancies, organ transplant recipients …
immunocompromised patients with hematological malignancies, organ transplant recipients …
Pneumocystis pneumonia in immunosuppressed patients-Epidemiological characterization and identification of diagnostic and prognostic markers
S Grønseth - 2023 - ntnuopen.ntnu.no
Background Pneumocystis jirovecii is an opportunistic fungus and the causative agent of
Pneumocystis pneumonia (PCP) in humans. PCP is foremost known as an AIDS-defining …
Pneumocystis pneumonia (PCP) in humans. PCP is foremost known as an AIDS-defining …